In contrast, in our experimental PH study, the observed increased PPARγ mRNA expression might be attributed to the compensatory mechanism to overcome PAH or, a secondary phenomenon due to increased adiponectin expression. The gene discussed is PPARG; the disease is pulmonary arterial hypertension.